Our Technologies
Our stem cell expansion and screening technologies have enabled us to generate quality-assured stem cell lines in quantities sufficient to treat many hundreds of thousands of potential patients. Read More ....
Our Products
We have developed stem cell therapies for serious conditions such as stroke disability where the patient populations are significant and where few if any alternative treatments exist. Read More ....
Share Price
To view detailed share price information
for ReNeuron Group plc. Click Here
Latest News
Guildford, UK, 19 April 2013: ReNeuron announces that later today it will be presenting important new pre-clinical data on the potential mechanisms by which its lead CTX stem cell line exerts its therapeutic
Guildford and London, UK - 28 March 2013: ReNeuron and the Cell Therapy Catapult, which is focused on the development of the UK cell therapy industry to increase the nation's health and wealth, are pleased to
Guildford, UK, 27 March 2013: ReNeuron provides an update on progress with its ReN001 stem cell therapy for disabled stroke